176 related articles for article (PubMed ID: 24317529)
21. p16INK4a hypermethylation and p53, p16 and MDM2 protein expression in esophageal squamous cell carcinoma.
Taghavi N; Biramijamal F; Sotoudeh M; Khademi H; Malekzadeh R; Moaven O; Memar B; A'rabi A; Abbaszadegan MR
BMC Cancer; 2010 Apr; 10():138. PubMed ID: 20388212
[TBL] [Abstract][Full Text] [Related]
22. DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas.
Nie Y; Yang G; Song Y; Zhao X; So C; Liao J; Wang LD; Yang CS
Carcinogenesis; 2001 Oct; 22(10):1615-23. PubMed ID: 11577000
[TBL] [Abstract][Full Text] [Related]
23. Study on RIZ1 gene promoter methylation status in human esophageal squamous cell carcinoma.
Dong SW; Zhang P; Liu YM; Cui YT; Wang S; Liang SJ; He Z; Sun P; Wang YG
World J Gastroenterol; 2012 Feb; 18(6):576-82. PubMed ID: 22363126
[TBL] [Abstract][Full Text] [Related]
24. Aberrant methylation of the 3q25 tumor suppressor gene PTX3 in human esophageal squamous cell carcinoma.
Wang JX; He YL; Zhu ST; Yang S; Zhang ST
World J Gastroenterol; 2011 Oct; 17(37):4225-30. PubMed ID: 22072855
[TBL] [Abstract][Full Text] [Related]
25. WNT5A antagonizes WNT/β-catenin signaling and is frequently silenced by promoter CpG methylation in esophageal squamous cell carcinoma.
Li J; Ying J; Fan Y; Wu L; Ying Y; Chan AT; Srivastava G; Tao Q
Cancer Biol Ther; 2010 Sep; 10(6):617-24. PubMed ID: 20603606
[TBL] [Abstract][Full Text] [Related]
26. Connective tissue growth factor expression in precancerous lesions of human esophageal epithelium and prognostic significance in esophageal squamous cell carcinoma.
Li LY; Li EM; Wu ZY; Huang X; Shen JH; Xu XE; Wu JY; Huang Q; Xu LY
Dis Esophagus; 2011 Jul; 24(5):337-45. PubMed ID: 21143696
[TBL] [Abstract][Full Text] [Related]
27. Hypermethylation of tachykinin-1 is a potential biomarker in human esophageal cancer.
Jin Z; Olaru A; Yang J; Sato F; Cheng Y; Kan T; Mori Y; Mantzur C; Paun B; Hamilton JP; Ito T; Wang S; David S; Agarwal R; Beer DG; Abraham JM; Meltzer SJ
Clin Cancer Res; 2007 Nov; 13(21):6293-300. PubMed ID: 17975140
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic inactivation of secreted frizzled-related protein 2 in esophageal squamous cell carcinoma.
Hao XW; Zhu ST; He YL; Li P; Wang YJ; Zhang ST
World J Gastroenterol; 2012 Feb; 18(6):532-40. PubMed ID: 22363119
[TBL] [Abstract][Full Text] [Related]
29. Promoter methylation of heat shock protein B2 in human esophageal squamous cell carcinoma.
Chang X; Yamashita K; Sidransky D; Kim MS
Int J Oncol; 2011 Apr; 38(4):1129-35. PubMed ID: 21258768
[TBL] [Abstract][Full Text] [Related]
30. Decreased Tumor Suppressor Candidate 3 Predicts Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma.
Yu X; Zhang J; Zhong H; Liu F; Liang N; Wang Y; Meng X; Du J
Int J Med Sci; 2016; 13(12):963-969. PubMed ID: 27994502
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of matrix metalloproteinase 10 is associated with poor survival in patients with early stage of esophageal squamous cell carcinoma.
Liu H; Qin YR; Bi J; Guo A; Fu L; Guan XY
Dis Esophagus; 2012; 25(7):656-63. PubMed ID: 22121946
[TBL] [Abstract][Full Text] [Related]
32. Expression of ECRG4, a novel esophageal cancer-related gene, downregulated by CpG island hypermethylation in human esophageal squamous cell carcinoma.
Yue CM; Deng DJ; Bi MX; Guo LP; Lu SH
World J Gastroenterol; 2003 Jun; 9(6):1174-8. PubMed ID: 12800218
[TBL] [Abstract][Full Text] [Related]
33. Expression of ECRG4 is an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.
Mori Y; Ishiguro H; Kuwabara Y; Kimura M; Mitsui A; Kurehara H; Mori R; Tomoda K; Ogawa R; Katada T; Harata K; Fujii Y
Oncol Rep; 2007 Oct; 18(4):981-5. PubMed ID: 17786363
[TBL] [Abstract][Full Text] [Related]
34. [Mechanism of loss of human esophageal cancer-related gene 4 (ECRG4) gene expression in esophageal squamous cell carcinoma cell line EC9706].
Li LW; Yu XY; Li XY; Guo LP; Zhou Y; Lu SX
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):570-3. PubMed ID: 22325214
[TBL] [Abstract][Full Text] [Related]
35. Transcriptome profiling of esophageal squamous cell carcinoma reveals a long noncoding RNA acting as a tumor suppressor.
Wei G; Luo H; Sun Y; Li J; Tian L; Liu W; Liu L; Luo J; He J; Chen R
Oncotarget; 2015 Jul; 6(19):17065-80. PubMed ID: 26158411
[TBL] [Abstract][Full Text] [Related]
36. Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma.
Yamashita K; Upadhyay S; Osada M; Hoque MO; Xiao Y; Mori M; Sato F; Meltzer SJ; Sidransky D
Cancer Cell; 2002 Dec; 2(6):485-95. PubMed ID: 12498717
[TBL] [Abstract][Full Text] [Related]
37. The relationship between the expression of VEGF, EGFR, and HER-2 mRNA in esophageal squamous cell carcinoma (ESCC) and clinicopathological features of different ethnic groups in Xinjiang.
Zhang L; Wang Y; Bai G; Zhang J; Yang M; Ma X
Tumour Biol; 2015 Dec; 36(12):9277-83. PubMed ID: 26099724
[TBL] [Abstract][Full Text] [Related]
38. DCC promoter hypermethylation in esophageal squamous cell carcinoma.
Park HL; Kim MS; Yamashita K; Westra W; Carvalho AL; Lee J; Jiang WW; Baek JH; Liu J; Osada M; Moon CS; Califano JA; Mori M; Sidransky D
Int J Cancer; 2008 Jun; 122(11):2498-502. PubMed ID: 18302152
[TBL] [Abstract][Full Text] [Related]
39. The detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinoma.
Ma K; Cao B; Guo M
Clin Epigenetics; 2016; 8():43. PubMed ID: 27110300
[TBL] [Abstract][Full Text] [Related]
40. E-cadherin expression is commonly downregulated by CpG island hypermethylation in esophageal carcinoma cells.
Si HX; Tsao SW; Lam KY; Srivastava G; Liu Y; Wong YC; Shen ZY; Cheung AL
Cancer Lett; 2001 Nov; 173(1):71-8. PubMed ID: 11578811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
